BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1596396)

  • 1. Adrenergic and nonadrenergic effects of imidazoline and related antihypertensive drugs in the brain and periphery.
    Hamilton CA
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):58S-63S. PubMed ID: 1596396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do centrally-acting antihypertensive drugs act at non-adrenergic as well as alpha-2 adrenoceptor sites?
    Hamilton CA; Yakubu MA; Howie CA; Reid JL
    Clin Exp Hypertens A; 1992; 14(5):815-35. PubMed ID: 1327589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization and down-regulation of brain alpha 2-adrenoceptors by centrally acting antihypertensive drugs.
    Hamilton CA; Yakubu MA; Howie CA; Jardine E; Reid JL
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):131S-134S. PubMed ID: 2176517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
    Sannajust F; Head GA
    Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol.
    Reid JL; Panfilov V; MacPhee G; Elliott HL
    Ann N Y Acad Sci; 1995 Jul; 763():673-8. PubMed ID: 7677387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits.
    Parkin ML; Godwin SJ; Head GA
    J Hypertens; 2003 Jan; 21(1):167-78. PubMed ID: 12544449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of imidazoline sites in rabbit kidney.
    Hamilton CA; Jardine E; Reid JL
    Eur J Pharmacol; 1993 Oct; 243(1):95-7. PubMed ID: 7902815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Chan CK; Sannajust F; Head GA
    J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of clonidine-like drugs in pithed rabbits.
    Pompermayer K; Salgado MC; Feldman J; Bousquet P
    Hypertension; 1999 Oct; 34(4 Pt 2):1012-5. PubMed ID: 10523400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does a second generation of centrally acting antihypertensive drugs really exist?
    Feldman J; Greney H; Monassier L; Vonthron C; Bruban V; Dontenwill M; Bousquet P
    J Auton Nerv Syst; 1998 Oct; 72(2-3):94-7. PubMed ID: 9851557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I1 receptors, cardiovascular function, and metabolism.
    Bousquet P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):317S-321S. PubMed ID: 11721890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.
    Szabo B; Fritz T; Wedzony K
    Br J Pharmacol; 2001 Sep; 134(2):295-304. PubMed ID: 11564647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonadrenergic imidazoline binding sites on human platelets.
    Piletz JE; Sletten K
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.
    Bousquet P; Feldman J; Tibirica E; Bricca G; Greney H; Dontenwill M; Stutzmann J; Belcourt A
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):47S-50S. PubMed ID: 1350728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine.
    van Zwieten PA
    J Hypertens; 1997 Feb; 15(2):117-25. PubMed ID: 9469786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.